{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T05:06:37Z","timestamp":1793336797136,"version":"4.5.0"},"reference-count":56,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2024,8,26]],"date-time":"2024-08-26T00:00:00Z","timestamp":1724630400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Infectious Disease Reports"],"abstract":"<jats:p>Critical illness causes disturbances in lipid metabolism. Here, we investigated the levels of apolipoprotein A-IV (apoA-IV), a regulator of triglyceride and cholesterol metabolism, in human sepsis. ApoA-IV (analyzed in 156 patients with systemic inflammatory response syndrome (SIRS)\/sepsis) and cholesteryl ester (CE) (analyzed in 121 of these patients) were lower in patients compared to 43 healthy controls. In contrast, triglyceride (TG) levels were elevated in patients. ApoA-IV levels in plasma of the patients did not correlate with these lipids. Patients with SIRS, sepsis or septic shock had comparable apoA-IV, TG, CE and free cholesterol (FC) levels. Patients on dialysis had significantly lower CE levels, whereas apoA-IV levels did not change much. CE levels were elevated in patients with viral sepsis due to SARS-CoV-2 infection in comparison to SIRS\/sepsis patients not infected by this virus. CE levels correlated negatively with procalcitonin, interleukin-6 and bilirubin, while TGs were positively associated with bilirubin and C-reactive protein. ApoA-IV, TG, CE and FC levels were not associated with bacterial infection or survival. In conclusion, this analysis suggests that CE levels decline in sepsis-related renal failure and also shows that plasma apoA-IV and CE levels are early biomarkers of sepsis.<\/jats:p>","DOI":"10.3390\/idr16050062","type":"journal-article","created":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T09:26:51Z","timestamp":1724750811000},"page":"806-819","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Lipid Metabolism Disorders as Diagnostic Biosignatures in Sepsis"],"prefix":"10.3390","volume":"16","author":[{"given":"Charlotte","family":"Birner","sequence":"first","affiliation":[{"name":"Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology, Rheumatology, and Infectious Diseases, University Hospital Regensburg, 93053 Regensburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Mester","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology, Rheumatology, and Infectious Diseases, University Hospital Regensburg, 93053 Regensburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4886-0811","authenticated-orcid":false,"given":"Gerhard","family":"Liebisch","sequence":"additional","affiliation":[{"name":"Institute of Clinical Chemistry and Laboratory Medicine, Regensburg University Hospital, 93053 Regensburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3651-392X","authenticated-orcid":false,"given":"Marcus","family":"H\u00f6ring","sequence":"additional","affiliation":[{"name":"Institute of Clinical Chemistry and Laboratory Medicine, Regensburg University Hospital, 93053 Regensburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2222-2926","authenticated-orcid":false,"given":"Stephan","family":"Schmid","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology, Rheumatology, and Infectious Diseases, University Hospital Regensburg, 93053 Regensburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"M\u00fcller","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology, Rheumatology, and Infectious Diseases, University Hospital Regensburg, 93053 Regensburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9473-3509","authenticated-orcid":false,"given":"Vlad","family":"Pavel","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology, Rheumatology, and Infectious Diseases, University Hospital Regensburg, 93053 Regensburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5635-3994","authenticated-orcid":false,"given":"Christa","family":"Buechler","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology, Rheumatology, and Infectious Diseases, University Hospital Regensburg, 93053 Regensburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,8,26]]},"reference":[{"key":"ref_1","first-page":"491","article-title":"Apolipoproteins A-I and B: Biosynthesis, role in the development of atherosclerosis and targets for intervention against cardiovascular disease","volume":"3","author":"Olofsson","year":"2007","journal-title":"Vasc. Health Risk Manag."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Florea, G., Tudorache, I.F., Fuior, E.V., Ionita, R., Dumitrescu, M., Fenyo, I.M., Bivol, V.G., and Gafencu, A.V. (2022). Apolipoprotein A-II, a Player in Multiple Processes and Diseases. Biomedicines, 10.","DOI":"10.3390\/biomedicines10071578"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1194\/jlr.R300019-JLR200","article-title":"Effects of infection and inflammation on lipid and lipoprotein metabolism: Mechanisms and consequences to the host","volume":"45","author":"Khovidhunkit","year":"2004","journal-title":"J. Lipid Res."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Kowalska, K., Sabatowska, Z., Forycka, J., Mlynarska, E., Franczyk, B., and Rysz, J. (2022). The Influence of SARS-CoV-2 Infection on Lipid Metabolism-The Potential Use of Lipid-Lowering Agents in COVID-19 Management. Biomedicines, 10.","DOI":"10.3390\/biomedicines10092320"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Zhao, M., Luo, Z., He, H., Shen, B., Liang, J., Zhang, J., Ye, J., Xu, Y., Wang, Z., and Ye, D. (2021). Decreased Low-Density Lipoprotein Cholesterol Level Indicates Poor Prognosis of Severe and Critical COVID-19 Patients: A Retrospective, Single-Center Study. Front. Med., 8.","DOI":"10.3389\/fmed.2021.585851"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1007\/s00134-009-1609-y","article-title":"Changes in HDL-associated apolipoproteins relate to mortality in human sepsis and correlate to monocyte and platelet activation","volume":"35","author":"Barlage","year":"2009","journal-title":"Intensive Care Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1164\/rccm.202105-1197TR","article-title":"The Many Roles of Cholesterol in Sepsis: A Review","volume":"205","author":"Hofmaenner","year":"2022","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12014-019-9252-2","article-title":"Lipid metabolism impairment in patients with sepsis secondary to hospital acquired pneumonia, a proteomic analysis","volume":"16","author":"Sharma","year":"2019","journal-title":"Clin. Proteomics"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Barker, G., Leeuwenburgh, C., Brusko, T., Moldawer, L., Reddy, S.T., and Guirgis, F.W. (2021). Lipid and Lipoprotein Dysregulation in Sepsis: Clinical and Mechanistic Insights into Chronic Critical Illness. J. Clin. Med., 10.","DOI":"10.3390\/jcm10081693"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1097\/CCM.0000000000005195","article-title":"Coronavirus Disease 2019 as Cause of Viral Sepsis: A Systematic Review and Meta-Analysis","volume":"49","author":"Karakike","year":"2021","journal-title":"Crit. Care Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.imlet.2022.07.003","article-title":"Soluble CD137 as a potential biomarker for severe COVID-19","volume":"248","author":"Marques","year":"2022","journal-title":"Immunol. Lett."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Begue, F., Chemello, K., Veeren, B., Lortat-Jacob, B., Tran-Dinh, A., Zappella, N., Snauwaert, A., Robert, T., Rondeau, P., and Lagrange-Xelot, M. (2023). Plasma Apolipoprotein Concentrations Are Highly Altered in Severe Intensive Care Unit COVID-19 Patients: Preliminary Results from the LIPICOR Cohort Study. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24054605"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"101751","DOI":"10.1016\/j.beem.2023.101751","article-title":"The bidirectional interaction of COVID-19 infections and lipoproteins","volume":"37","author":"Feingold","year":"2023","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Qu, J., Ko, C.W., Tso, P., and Bhargava, A. (2019). Apolipoprotein A-IV: A Multifunctional Protein Involved in Protection against Atherosclerosis and Diabetes. Cells, 8.","DOI":"10.3390\/cells8040319"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"G472","DOI":"10.1152\/ajpgi.00098.2014","article-title":"ApoA-IV: Current and emerging roles in intestinal lipid metabolism, glucose homeostasis, and satiety","volume":"308","author":"Kohan","year":"2015","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1079\/BJN19970025","article-title":"Postprandial lipaemia is associated with increased levels of apolipoprotein A-IV in the triacylglycerol-rich fraction and decreased levels in the denser plasma fractions","volume":"77","author":"Dallongeville","year":"1997","journal-title":"Br. J. Nutr."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0021-9150(88)90161-X","article-title":"Changes of serum apolipoprotein levels after oral administration of fat in human subjects","volume":"73","author":"Seishima","year":"1988","journal-title":"Atherosclerosis"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1161\/01.ATV.0000119353.03690.22","article-title":"Human apolipoprotein A-IV reduces secretion of proinflammatory cytokines and atherosclerotic effects of a chronic infection mimicked by lipopolysaccharide","volume":"24","author":"Recalde","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1172\/JCI200421233","article-title":"Apolipoprotein A-IV inhibits experimental colitis","volume":"114","author":"Vowinkel","year":"2004","journal-title":"J. Clin. Investig."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Shearston, K., Tan, J.T.M., Cochran, B.J., and Rye, K.A. (2022). Inhibition of Vascular Inflammation by Apolipoprotein A-IV. Front. Cardiovasc. Med., 9.","DOI":"10.3389\/fcvm.2022.901408"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/all.14022","article-title":"Apolipoprotein A-IV acts as an endogenous anti-inflammatory protein and is reduced in treatment-naive allergic patients and allergen-challenged mice","volume":"75","author":"Roula","year":"2020","journal-title":"Allergy"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.atherosclerosis.2004.04.018","article-title":"Apolipoproteins A-IV and A-V are acute-phase proteins in mouse HDL","volume":"176","author":"Khovidhunkit","year":"2004","journal-title":"Atherosclerosis"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e10807","DOI":"10.1016\/j.heliyon.2022.e10807","article-title":"Identification of candidate biomarkers for severe adenovirus community-acquired pneumonia by proteomic approach","volume":"8","author":"Shi","year":"2022","journal-title":"Heliyon"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.xkme.2021.02.007","article-title":"Sepsis-Associated Acute Kidney Disease and Long-term Kidney Outcomes","volume":"3","author":"Flannery","year":"2021","journal-title":"Kidney Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/MOL.0000000000000371","article-title":"Apolipoprotein L1 and apolipoprotein A-IV and their association with kidney function","volume":"28","author":"Kronenberg","year":"2017","journal-title":"Curr. Opin. Lipidol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1194\/jlr.M600178-JLR200","article-title":"Role of the kidney in the metabolism of apolipoprotein A-IV: Influence of the type of proteinuria","volume":"47","author":"Lingenhel","year":"2006","journal-title":"J. Lipid Res."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Romanova, Y., Laikov, A., Markelova, M., Khadiullina, R., Makseev, A., Hasanova, M., Rizvanov, A., Khaiboullina, S., and Salafutdinov, I. (2020). Proteomic Analysis of Human Serum from Patients with Chronic Kidney Disease. Biomolecules, 10.","DOI":"10.3390\/biom10020257"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"e12937","DOI":"10.1111\/eci.12937","article-title":"Serum ApoA4 levels predicted the progression of renal impairment in T2DM","volume":"48","author":"Cheng","year":"2018","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1001\/jama.1995.03520260077036","article-title":"Sepsis, sepsis syndrome, and the systemic inflammatory response syndrome (SIRS). Gulliver in Laputa","volume":"273","author":"Bone","year":"1995","journal-title":"JAMA"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1139\/y59-099","article-title":"A rapid method of total lipid extraction and purification","volume":"37","author":"Bligh","year":"1959","journal-title":"Can. J. Biochem. Physiol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s12944-022-01715-w","article-title":"Sex-specific changes in triglyceride profiles in liver cirrhosis and hepatitis C virus infection","volume":"21","author":"Peschel","year":"2022","journal-title":"Lipids Health Dis."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"100050","DOI":"10.1016\/j.jlr.2021.100050","article-title":"Accurate quantification of lipid species affected by isobaric overlap in Fourier-transform mass spectrometry","volume":"62","author":"Horing","year":"2021","journal-title":"J. Lipid Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.1021\/acs.analchem.8b05013","article-title":"Quantification of Cholesterol and Cholesteryl Ester by Direct Flow Injection High-Resolution Fourier Transform Mass Spectrometry Utilizing Species-Specific Response Factors","volume":"91","author":"Horing","year":"2019","journal-title":"Anal. Chem."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e0860","DOI":"10.1097\/CCE.0000000000000860","article-title":"Association Between Hypocholesterolemia and Mortality in Critically Ill Patients with Sepsis: A Systematic Review and Meta-Analysis","volume":"5","author":"Hofmaenner","year":"2023","journal-title":"Crit. Care Explor."},{"key":"ref_36","unstructured":"Feingold, K.R., Anawalt, B., Blackman, M.R., Boyce, A., Chrousos, G., Corpas, E., de Herder, W.W., Dhatariya, K., Dungan, K., and Hofland, J. (2000). The Effect of Inflammation and Infection on Lipids and Lipoproteins. Endotext, MDText.com, Inc."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/s13054-022-04090-1","article-title":"The gut-liver axis in sepsis: Interaction mechanisms and therapeutic potential","volume":"26","author":"Zhang","year":"2022","journal-title":"Crit. Care"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12950-015-0069-0","article-title":"TNF-alpha and IL-6 inhibit apolipoprotein A-IV production induced by linoleic acid in human intestinal Caco2 cells","volume":"12","author":"Li","year":"2015","journal-title":"J. Inflamm."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1002\/jgh3.12771","article-title":"Pathophysiology of sepsis-induced cholestasis: A review","volume":"6","author":"Ghenu","year":"2022","journal-title":"JGH Open"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"780","DOI":"10.18632\/aging.203839","article-title":"Integrin alphaEbeta7 is involved in the intestinal barrier injury of sepsis","volume":"14","author":"Sun","year":"2022","journal-title":"Aging"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1055\/s-2007-984466","article-title":"The satiety factor apolipoprotein A-IV modulates intestinal epithelial permeability through its interaction with alpha-catenin: Implications for inflammatory bowel diseases","volume":"39","author":"Orso","year":"2007","journal-title":"Horm. Metab. Res."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"3560","DOI":"10.1074\/jbc.M506360200","article-title":"E-cadherin-dependent transcriptional control of apolipoprotein A-IV gene expression in intestinal epithelial cells: A role for the hepatic nuclear factor 4","volume":"281","author":"Peignon","year":"2006","journal-title":"J. Biol. Chem."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Buechler, C., and Aslanidis, C. (2020). Role of lipids in pathophysiology, diagnosis and therapy of hepatocellular carcinoma. Biochim. Biophys. Acta Mol. Cell Biol. Lipids, 1865.","DOI":"10.1016\/j.bbalip.2020.158658"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"88951","DOI":"10.18632\/oncotarget.21627","article-title":"Proteome-based identification of apolipoprotein A-IV as an early diagnostic biomarker in liver fibrosis","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0928-4346(95)00240-5","article-title":"Reduced intestinal apo A-IV mRNA levels in patients with liver cirrhosis","volume":"4","author":"Seishima","year":"1995","journal-title":"Int. Hepatol. Commun."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Reisinger, A.C., Schuller, M., Sourij, H., Stadler, J.T., Hackl, G., Eller, P., and Marsche, G. (2021). Impact of Sepsis on High-Density Lipoprotein Metabolism. Front. Cell Dev. Biol., 9.","DOI":"10.3389\/fcell.2021.795460"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Taylor, R., Zhang, C., George, D., Kotecha, S., Abdelghaffar, M., Forster, T., Santos Rodrigues, P.D., Reisinger, A.C., White, D., and Hamilton, F. (2024). Low circulatory levels of total cholesterol, HDL-C and LDL-C are associated with death of patients with sepsis and critical illness: Systematic review, meta-analysis, and perspective of observational studies. eBioMedicine, 100.","DOI":"10.1016\/j.ebiom.2024.104981"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/ki.2013.181","article-title":"LDL cholesterol in CKD\u2014To treat or not to treat?","volume":"84","author":"Massy","year":"2013","journal-title":"Kidney Int."},{"key":"ref_49","first-page":"e47272","article-title":"The Decrease in Serum Total Cholesterol and Low-Density Lipoprotein (LDL) Concentrations with the Initiation of Hemodialysis Despite a Concomitant Increase in Serum Albumin Concentrations","volume":"15","author":"Sam","year":"2023","journal-title":"Cureus"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Stasi, A., Franzin, R., Fiorentino, M., Squiccimarro, E., Castellano, G., and Gesualdo, L. (2021). Multifaced Roles of HDL in Sepsis and SARS-CoV-2 Infection: Renal Implications. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22115980"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/joim.12380","article-title":"Association between apolipoprotein A-IV concentrations and chronic kidney disease in two large population-based cohorts: Results from the KORA studies","volume":"278","author":"Stangl","year":"2015","journal-title":"J. Intern. Med."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"117270","DOI":"10.1016\/j.atherosclerosis.2023.117270","article-title":"Sex differences in lipids: A life course approach","volume":"384","author":"Holven","year":"2023","journal-title":"Atherosclerosis"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.2337\/dc18-0372","article-title":"LDL Cholesterol Rises with BMI Only in Lean Individuals: Cross-sectional U.S. and Spanish Representative Data","volume":"41","author":"Laclaustra","year":"2018","journal-title":"Diabetes Care"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"591","DOI":"10.12669\/pjms.35.3.7","article-title":"Correlation between Body Mass Index and Lipid Profile in patients with Type 2 Diabetes attending a tertiary care hospital in Peshawar","volume":"35","author":"Hussain","year":"2019","journal-title":"Pak. J. Med. Sci."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1016\/S0022-2275(20)31531-5","article-title":"Increased plasma apoA-IV level is a marker of abnormal postprandial lipemia: A study in normoponderal and obese subjects","volume":"42","author":"Verges","year":"2001","journal-title":"J. Lipid Res."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0021-9150(99)00395-0","article-title":"Effects of age, gender, and lifestyle factors on plasma apolipoprotein A-IV concentrations","volume":"151","author":"Sun","year":"2000","journal-title":"Atherosclerosis"}],"container-title":["Infectious Disease Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2036-7449\/16\/5\/62\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:42:45Z","timestamp":1760110965000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2036-7449\/16\/5\/62"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,26]]},"references-count":56,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,10]]}},"alternative-id":["idr16050062"],"URL":"https:\/\/doi.org\/10.3390\/idr16050062","relation":{},"ISSN":["2036-7449"],"issn-type":[{"value":"2036-7449","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,26]]}}}